Figure 2.
Changes in MAGE and in plasma nitrotyrosine, IL-6, and IL-18 levels in vildagliptin (VILDA) and sitagliptin (SITA) group are shown after 3 months of therapy. *P < 0.05.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.